🔥 biotech 핫 테마 분석

[VRTX] Vertex reports positive mid-stage results of inaxaplin for kidney disease

[LNTH] Lantheus gains approval of Bravnesta, generic competitor to Lutathera

S-Class [AMGN] Amgen gains on late-stage trial win for Sjögren's disease therapy

[OMER] Cantor Fitzgerald upgrades Omeros stock rating on Yartemlea launch

S-Class [MRNA] Moderna rallies 12% to set new high

[LLY] Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs

They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.

[CADL] Candel upgraded at BofA on prostate cancer gene therapy